Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Gland Pharma Limited Call Transcript 2025

Oct 17, 2025

59319_rns_2025-10-17_87e0ed6c-1106-40f1-b0a1-9b9338997cf1.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [59 x 48] intentionally omitted <==

==> picture [298 x 20] intentionally omitted <==

October 17, 2025

BSE Limited Corporate Relationship Department Phiroze Jeejeebhoy Towers 25[th] floor, Dalal Street Mumbai - 400 001 Scrip Code: 543245

National Stock Exchange of India Limited Listing Department Exchange Plaza, 5th floor Plot no. C-1, Block G, Bandra Kurla Complex Bandra (East), Mumbai - 400 051 Symbol: GLAND (ISIN: INE068V01023)

Dear Sir/Madam,

Sub: Earnings Conference Call

We hereby inform you that the Earnings Call for Investors/Analysts will be held on Monday , November 3, 2025, at 18:30 hours (IST) for 60 minutes to discuss the Company's financial performance and business updates for the quarter and half year ended September 30, 2025.

The details of the Earnings Call for Investors/Analysts are enclosed.

The transcript and the audio recording of the Earnings Call will be made available on the Company’s website.

This is for your information and records.

Yours truly, For Gland Pharma Limited

Digitally signed by Pallerlamudi Pallerlamudi Sampath KumarDN: cn=Pallerlamudi Sampath Kumar, c=IN, o=Personal, Sampath Kumar [email protected] Date: 2025.10.17 16:05:12 +05'30'

Sampath Kumar Pallerlamudi Company Secretary & Compliance Officer

Encl: As above

==> picture [580 x 78] intentionally omitted <==

==> picture [69 x 51] intentionally omitted <==

EARNINGS CONFERENCE CALL FOR Q2 FY26

The Company will host an earnings conference call for the Q2 FY26 on Monday, November 3, 2025, at 18:30 Hours (IST) .

During the call, the management team will discuss the performance and take questions related to the business. The audio recording and transcript of the conference call will be available after the call on the Company’s website at www.glandpharma.com.

Earnings Conference Dial-In Information
Earnings Conference Dial-In Information
Earnings Conference Dial-In Information
Earnings Conference Dial-In Information
Diamond pass link
Diamond pass link
Clickhereto register
Clickhere to register
Universal Access
Universal Access
+91 22 6280 1516
+91 22 7115 8875
+91 22 6280 1516
+91 22 7115 8875
International Toll-Free Number
International Toll-Free Number
USA – 18667462133
UK – 08081011573
Singapore – 8001012045
HongKong– 800964448
USA- 18667462133
UK- 08081011573
Singapore -8001012045
HongKong -800964448

Contact:

Sampath Kumar Pallerlamudi Shriniwas Pradeep Dange Company Secretary and Compliance Officer Investor Relations [email protected]